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Background: Sarcoidosis, an inflammatory granulomatous disease, is associated with various cardiac disorders, including threatening ventricular 
arrhythmias and sudden cardiac death. Heart rate recovery after exercise is a function of vagal reactivation, and its impairment is an independent 
prognostic indicator for cardiovascular and all-cause mortality. The aim of our study was to evaluate heart rate recovery in patients with sarcoidosis.
Methods:  The study population included 56 patients with sarcoidosis(23 men, mean age 47.3 years,and mean disease duration 38.4 months) 
and 54 healthy control subjects.Basal electrocardiography, echocardiography, and treadmill exercise testing were performed on all patients and 
control participants. The heart rate recovery index was defined as the reduction in the heart rate at peak exercise to the 1st-minute rate (HRR1), 
2nd-minute (HRR2), 3rd-minute (HRR3) and 5th-minute (HRR5) after the cessation of exercise stress testing.
Results:  There are significant differences in HRR1 and HRR2 indices between patients with sarcoidosis and the control group (25 ± 6 vs 34 ± 
11; p<0.001 and 45 ± 10 vs 53 ± 12; p<0.001, respectively). Similarly, HRR3 and HRR5 indices of the recovery period were lower in patients with 
sarcoidosis, when compared with indices in the control group (53 ± 12 vs 61 ± 13; p<0.001 and 60 ± 13 vs 68 ± 13; p<0.001, respectively). 
Exercise capacity was notably lower (9.2 ± 2.1 vs 11.6 ± 2.8 METs; p=0.001) and systolic pulmonary arterial pressure at rest was significantly higher 
in patients with sarcoidosis compared with the control group (29.7 ± 5.5 mm Hg vs. 25.6 ± 5.7 mm Hg, p = 0.001, respectively). Furthermore, HRR 
indices were found to be different among radiographic stage groups.
Conclusions:  The heart rate recovery index was impaired in patients with sarcoidosis as compared with control subjects. When the prognostic 
significance of the heart rate recovery index is considered, these results may partially explain the increased occurrence of arrhythmias and sudden 
cardiac death in patients with sarcoidosis. Our findings suggest that the heart rate recovery index may be clinically helpful in identifying high risk 
patients with sarcoidosis.
